Anterix (ATEX) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Anterix (ATEX) over the last 6 years, with Q4 2025 value amounting to -$0.35.
- Anterix's EPS (Weighted Average and Diluted) fell 18536.59% to -$0.35 in Q4 2025 from the same period last year, while for Dec 2025 it was $4.36, marking a year-over-year increase of 36913.58%. This contributed to the annual value of -$0.61 for FY2025, which is 2594.44% down from last year.
- Per Anterix's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.35 for Q4 2025, which was down 18536.59% from $2.86 recorded in Q3 2025.
- Over the past 5 years, Anterix's EPS (Weighted Average and Diluted) peaked at $2.86 during Q3 2025, and registered a low of -$0.84 during Q2 2024.
- In the last 5 years, Anterix's EPS (Weighted Average and Diluted) had a median value of -$0.38 in 2022 and averaged -$0.04.
- Within the past 5 years, the most significant YoY rise in Anterix's EPS (Weighted Average and Diluted) was 228535.84% (2024), while the steepest drop was 72727.27% (2024).
- Anterix's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.69 in 2021, then surged by 39.13% to -$0.42 in 2022, then skyrocketed by 104.09% to $0.02 in 2023, then soared by 2285.36% to $0.41 in 2024, then plummeted by 185.37% to -$0.35 in 2025.
- Its last three reported values are -$0.35 in Q4 2025, $2.86 for Q3 2025, and $1.35 during Q2 2025.